In a recent news release, the US Food and Drug Administration (FDA) said that Johnson & Johnson (JNJ)’s abiraterone acetate - a pill that will be marketed as Zytiga – has been approved for use in late-stage prostate cancer patients who had earlier received chemotherapy.
 

Glioblastoma is a fatal brain tumor and the FDA has been advised that a new device to treat this condition has to be to be approved.
 
What advisory panel states is not what the FDA is suppose to follow but in normal course of action, the FDA does follow the recommendations.
 

The US Food and Drug Administration have approved the manufacturing of prostate-cancer drug Provenge. This drug would be manufactured by Dendreon Corp. at its New Jersey manufacturing unit.
 
Immediately after the approval the shares have seen a hike of 2.1% and closed at $32.91 on Thursday. 
 

The U. S. Food and Drug Administration have planned to remove the unapproved prescription drugs from pharmacies. These drugs would have been rejected due to the health and safety reasons. The drugs have not been evaluated by the FDA and may pose a risk to the patients.

E. coli infected two Minnesotans and following this the Washington company that made the cheese was forced to order a recall of its cheese products.

An outbreak that led to a nationwide recall Friday of artisanal cheese made from raw milk might have been linked to the two Minnesota E. coli cases.

The Fridley Company's Arctic Front system that uses a freezing technology has been approved by the FDA.

Approval for a device to treat an irregular beating of the heart's upper chambers that can lead to a stroke according to Medtronic was given by the FDA.